基本资料 投资组合 财务数据 基金公告
标普生物科技ETF嘉实(159502) |
净值：
1.3735
|
日增长率：
0.66%
|
累计净值：1.3735 | 2026-05-13 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| APLS | Apellis Pharmaceuticals Inc | 114,347.00 | 31,830,484.18 | 1.83 |
| ALKS | 阿尔凯默斯 | 102,911.00 | 25,179,232.72 | 1.45 |
| MDGL | Madrigal Pharmaceuticals Inc | 6,623.00 | 23,989,157.16 | 1.38 |
| TGTX | TG Therapeutics Inc | 101,884.00 | 23,419,307.69 | 1.35 |
| INSM | Insmed Inc | 20,501.00 | 23,196,067.36 | 1.34 |
| SRRK | Scholar Rock Holding Corp | 66,184.00 | 22,512,997.48 | 1.30 |
| APGE | Apogee Therapeutics Inc | 38,268.00 | 22,287,508.90 | 1.28 |
| PTGX | Protagonist Therapeutics Inc | 29,621.00 | 21,602,736.30 | 1.24 |
| SMMT | Summit Therapeutics Inc | 164,150.00 | 21,535,137.91 | 1.24 |
| UTHR | 联合治疗 | 5,247.00 | 21,528,786.32 | 1.24 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 99.74 | - | 8.86 | 1,736,807,535.75 |
| 2025-12-31 | 99.58 | - | 0.50 | 2,211,867,188.77 |
| 2025-09-30 | 99.38 | - | 0.69 | 1,523,149,285.27 |
| 2025-06-30 | 99.24 | - | 0.81 | 1,231,192,496.86 |
| 2025-03-31 | 99.48 | - | 2.07 | 1,073,213,261.21 |
微信公众号
证券之星APP
